Discontinuation report PRIMAXIN 500
Report ID | 149907 |
Drug Identification Number | 00717282 |
Brand name | PRIMAXIN 500 |
Common or Proper name | imipenem and cilastatin sodium for injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CILASTATIN IMIPENEM |
Strength(s) | 500MG 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500MG X 25 VIAL 20ML |
ATC code | J01DH |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-07-02 |
Actual discontinuation date | 2022-06-30 |
Remaining supply date | 2022-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-07-01 | English | Compare |
v10 | 2022-06-30 | French | Compare |
v9 | 2022-06-30 | English | Compare |
v8 | 2022-04-05 | French | Compare |
v7 | 2022-04-05 | English | Compare |
v6 | 2022-03-29 | French | Compare |
v5 | 2022-03-29 | English | Compare |
v4 | 2022-02-24 | French | Compare |
v3 | 2022-02-24 | English | Compare |
v2 | 2021-11-25 | French | Compare |
v1 | 2021-11-25 | English | Compare |
Showing 1 to 11 of 11